Georgetown Lombardi, Washington's only National Cancer Institute-designated Comprehensive Cancer Center, works with other institutions - MedStar Health and the John Theurer Cancer Center - to broaden its research capacity.
We are developing and testing the cancer treatments of tomorrow - targeted therapies that will improve both survival and quality of life.
Award-winning physicians, state-of-the-art facilities, and a high commitment to excellence—qualities that make Lombardi stand out above the rest!
Educating and training tomorrow's leaders in cancer treatment and research is our mission.
Discover what distinguishes Georgetown Lombardi Comprehensive Cancer Center,
Washington, D.C.’s only National Cancer Institute-designated Comprehensive Cancer Center.
Georgetown University President John J. DeGioia discusses the significance of Georgetown Lombardi's research.
Meet 
Georgetown University Medical Center is an internationally recognized academic health and science center with a four-part mission of research, teaching, service and patient care (provided through a partnership with MedStar Health).
Lombardi News Stories
-
Washington Women Raise $735K for Breast Cancer Research at Georgetown Lombardi
-
Genetic Testing in Women Diagnosed with Breast Cancer Decreases Cost of Care Nationwide
-
Continence Confidence: Prostatectomy Patients Reporting ‘Startling’ Success After Robotic Retzius-Sparing Surgery
-
Rare but Important Gene Target Found in Many Tumor Types, Suggesting New Therapy Possible